77 related articles for article (PubMed ID: 12518653)
21. Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep.
Sachse A; Wagner A; Keller M; Wagner O; Wetzel WD; Layher F; Venbrocks RA; Hortschansky P; Pietraszczyk M; Wiederanders B; Hempel HJ; Bossert J; Horn J; Schmuck K; Mollenhauer J
Bone; 2005 Nov; 37(5):699-710. PubMed ID: 16139577
[TBL] [Abstract][Full Text] [Related]
22. Periodontal repair in dogs: effect of recombinant human bone morphogenetic protein-12 (rhBMP-12) on regeneration of alveolar bone and periodontal attachment.
Wikesjö UM; Sorensen RG; Kinoshita A; Jian Li X; Wozney JM
J Clin Periodontol; 2004 Aug; 31(8):662-70. PubMed ID: 15257745
[TBL] [Abstract][Full Text] [Related]
23. [Bone morphogenic proteins (BMPs) and bone repair].
Marie P
Rev Chir Orthop Reparatrice Appar Mot; 2000 Sep; 86 Suppl 1():151-2. PubMed ID: 11084518
[No Abstract] [Full Text] [Related]
24. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.
Singhatanadgit W; Salih V; Olsen I
Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965
[TBL] [Abstract][Full Text] [Related]
25. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
[TBL] [Abstract][Full Text] [Related]
26. [In vitro osteogenesis of the compound of chitosan and recombinant human bone morphogenetic protein 2].
Liang D; Zuo A; Wang B; Zhang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Sep; 19(9):721-4. PubMed ID: 16206761
[TBL] [Abstract][Full Text] [Related]
27. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
Liu HW; Chen CH; Tsai CL; Hsiue GH
Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
[TBL] [Abstract][Full Text] [Related]
28. Bone regeneration in dehiscence-type defects at chemically modified (SLActive) and conventional SLA titanium implants: a pilot study in dogs.
Schwarz F; Herten M; Sager M; Wieland M; Dard M; Becker J
J Clin Periodontol; 2007 Jan; 34(1):78-86. PubMed ID: 17137467
[TBL] [Abstract][Full Text] [Related]
29. [Reconstruction of maxillary sinus lateral bone wall and mucosa defect of with collagen sponge and acellular cancellous bone combined with bone morphogenetic protein-2].
Li XS; Sun JJ
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1276-8. PubMed ID: 17686267
[TBL] [Abstract][Full Text] [Related]
30. Short-period effects of zirconia and titanium on osteoblast microRNAs.
Palmieri A; Pezzetti F; Brunelli G; Lo Muzio L; Scarano A; Scapoli L; Martinelli M; Arlotti M; Guerzoni L; Rubini C; Carinci F
Clin Implant Dent Relat Res; 2008 Sep; 10(3):200-5. PubMed ID: 18241218
[TBL] [Abstract][Full Text] [Related]
31. Osteogenic effects of bone-morphogenetic-protein-2 plasmid gene transfer.
Seol YJ; Kim KH; Park YJ; Lee YM; Ku Y; Rhyu IC; Lee SJ; Han SB; Chung CP
Biotechnol Appl Biochem; 2008 Jan; 49(Pt 1):85-96. PubMed ID: 17608624
[TBL] [Abstract][Full Text] [Related]
32. Repair of long intercalated rib defects using porous beta-tricalcium phosphate cylinders containing recombinant human bone morphogenetic protein-2 in dogs.
Hoshino M; Egi T; Terai H; Namikawa T; Takaoka K
Biomaterials; 2006 Oct; 27(28):4934-40. PubMed ID: 16759693
[TBL] [Abstract][Full Text] [Related]
33. A randomized-controlled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP-2.
Jung RE; Windisch SI; Eggenschwiler AM; Thoma DS; Weber FE; Hämmerle CH
Clin Oral Implants Res; 2009 Jul; 20(7):660-6. PubMed ID: 19489935
[TBL] [Abstract][Full Text] [Related]
34. Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2.
Fu YC; Nie H; Ho ML; Wang CK; Wang CH
Biotechnol Bioeng; 2008 Mar; 99(4):996-1006. PubMed ID: 17879301
[TBL] [Abstract][Full Text] [Related]
35. Periodontal repair in dogs: evaluation of a bioresorbable calcium phosphate cement (Ceredex) as a carrier for rhBMP-2.
Sorensen RG; Wikesjö UM; Kinoshita A; Wozney JM
J Clin Periodontol; 2004 Sep; 31(9):796-804. PubMed ID: 15312104
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profile on chitosan/rhBMP-2 films: A novel osteoinductive coating for implantable materials.
Abarrategi A; García-Cantalejo J; Moreno-Vicente C; Civantos A; Ramos V; Casado JV; Pérez-Rial S; Martńez-Corriá R; López-Lacomba JL
Acta Biomater; 2009 Sep; 5(7):2633-46. PubMed ID: 19342322
[TBL] [Abstract][Full Text] [Related]
37. The effect of pretreating morselized allograft bone with rhBMP-2 and/or pamidronate on the fixation of porous Ti and HA-coated implants.
Baas J; Elmengaard B; Jensen TB; Jakobsen T; Andersen NT; Soballe K
Biomaterials; 2008 Jul; 29(19):2915-22. PubMed ID: 18407348
[TBL] [Abstract][Full Text] [Related]
38. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
[TBL] [Abstract][Full Text] [Related]
39. [Effects of bone morphogenetic protein-2 gene therapy on the bone-implant interface: an experimental study with dogs].
Yan MN; Tang TT; Zhu ZA; Zhou XS; Jia QW; Yu CF; Lou JR; Dai KR
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1521-5. PubMed ID: 16179108
[TBL] [Abstract][Full Text] [Related]
40. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6.
Hennig T; Lorenz H; Thiel A; Goetzke K; Dickhut A; Geiger F; Richter W
J Cell Physiol; 2007 Jun; 211(3):682-91. PubMed ID: 17238135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
